レミケード・バイオシミラーの世界市場レポート 2023年以下1)タイプ別タイプ別:100mg/10ml、500mg/50ml2)適応疾患別:潰瘍性大腸炎、関節リウマチ、強直性脊椎炎、クローン病潰瘍性大腸炎、関節リウマチ、強直性脊椎炎、クローンズ病、乾癬性関節炎、プラーク乾癬3) 用途別:血液疾患;がん疾患対象疾患アッヴィ社; ノバルティス社; アムジェン社; ヴィアトリス社; テバ社Remicade Biosimilar Global Market Report 2023Including: 1) By Type: 100mg/10ml; 500mg/50ml2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohns Disease; Psoriatic Arthritis; Plaque Psoriasis3) By Application: Blood Disorders; Oncology DiseasesCovering: AbbVie Inc.; Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd. The Business Research Companyのレミケードバイオシミラーの世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 このレポートは力強い... もっと見る
サマリーThe Business Research Companyのレミケードバイオシミラーの世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。このレポートは力強い成長を遂げているレミケードバイオシミラー市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真のグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3~5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 レミケード・バイオシミラーの市場が最も大きく、急成長しているのはどこか?経済全体、人口動態、他の類似市場との関連は?今後どのような力が市場を形成していくのか?ビジネスリサーチ社のレミケードバイオシミラー世界市場レポートがこれらすべての疑問やその他多くの疑問にお答えします。 当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場:1) タイプ別100mg/10ml、500mg/50ml 2) 疾患別適応症適応疾患別:潰瘍性大腸炎、関節リウマチ、強直性脊椎炎、クローン病、関節症性乾癬、尋常性乾癬 3) 用途別血液疾患;腫瘍疾患 言及された企業アッヴィ社、ノバルティス社、アムジェン社、ヴィアトリス社、テバ・ファーマシューティカル・インダストリーズ社、アムジェン社、アムジェン社、アムジェン社、テバ・ファーマシューティカル・インダストリーズ社 国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分:国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Remicade Biosimilar Market Characteristics 3. Remicade Biosimilar Market Trends And Strategies 4. Remicade Biosimilar Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Remicade Biosimilar Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Remicade Biosimilar Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Remicade Biosimilar Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Remicade Biosimilar Market Segmentation 6.1. Global Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 100mg/10ml 500mg/50ml 6.2. Global Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Ulcerative Colitis Rheumatoid Arthritis Ankylosing Spondylitis Crohn’s Disease Psoriatic Arthritis Plaque Psoriasis 6.3. Global Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Blood Disorders Oncology Diseases 7. Remicade Biosimilar Market Regional And Country Analysis 7.1. Global Remicade Biosimilar Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Remicade Biosimilar Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Remicade Biosimilar Market 8.1. Asia-Pacific Remicade Biosimilar Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Remicade Biosimilar Market 9.1. China Remicade Biosimilar Market Overview 9.2. China Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Remicade Biosimilar Market 10.1. India Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Remicade Biosimilar Market 11.1. Japan Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Remicade Biosimilar Market 12.1. Australia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Remicade Biosimilar Market 13.1. Indonesia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Remicade Biosimilar Market 14.1. South Korea Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Remicade Biosimilar Market 15.1. Western Europe Remicade Biosimilar Market Overview 15.2. Western Europe Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Remicade Biosimilar Market 16.1. UK Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Remicade Biosimilar Market 17.1. Germany Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Remicade Biosimilar Market 18.1. France Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Remicade Biosimilar Market 19.1. Italy Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Remicade Biosimilar Market 20.1. Spain Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Remicade Biosimilar Market 21.1. Eastern Europe Remicade Biosimilar Market Overview 21.2. Eastern Europe Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Remicade Biosimilar Market 22.1. Russia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Remicade Biosimilar Market 23.1. North America Remicade Biosimilar Market Overview 23.2. North America Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Remicade Biosimilar Market 24.1. USA Remicade Biosimilar Market Overview 24.2. USA Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Remicade Biosimilar Market 25.1. Canada Remicade Biosimilar Market Overview 25.2. Canada Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Remicade Biosimilar Market 26.1. South America Remicade Biosimilar Market Overview 26.2. South America Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Remicade Biosimilar Market 27.1. Brazil Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Remicade Biosimilar Market 28.1. Middle East Remicade Biosimilar Market Overview 28.2. Middle East Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Remicade Biosimilar Market 29.1. Africa Remicade Biosimilar Market Overview 29.2. Africa Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Remicade Biosimilar Market Competitive Landscape And Company Profiles 30.1. Remicade Biosimilar Market Competitive Landscape 30.2. Remicade Biosimilar Market Company Profiles 30.2.1. AbbVie Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Novartis AG 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Amgen Inc 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Viatris Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Teva Pharmaceutical Industries Ltd. 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Remicade Biosimilar Market Other Major And Innovative Companies 31.1. Biogen Inc. 31.2. Organon & Co. 31.3. Merck And Co. Inc. 31.4. Janssen Biotech Inc. 31.5. LG Chem Ltd. 31.6. Nippon Kayaku Co. Ltd. 31.7. Celltrion Inc. 31.8. Nichi-iko Pharmaceutical Co. Ltd. 31.9. Biocon Limited 31.10. Alvogen Inc 31.11. Synthon International Holding B.V. 31.12. Coherus Biosciences Inc 31.13. Cardinal Health Inc 31.14. Genentech Inc. 31.15. Alvotech S.A. 32. Global Remicade Biosimilar Market Competitive Benchmarking 33. Global Remicade Biosimilar Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Remicade Biosimilar Market 35. Remicade Biosimilar Market Future Outlook and Potential Analysis 35.1 Remicade Biosimilar Market In 2027 - Countries Offering Most New Opportunities 35.2 Remicade Biosimilar Market In 2027 - Segments Offering Most New Opportunities 35.3 Remicade Biosimilar Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryRemicade Biosimilar Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Remicade Biosimilar Market Characteristics 3. Remicade Biosimilar Market Trends And Strategies 4. Remicade Biosimilar Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Remicade Biosimilar Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Remicade Biosimilar Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Remicade Biosimilar Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Remicade Biosimilar Market Segmentation 6.1. Global Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 100mg/10ml 500mg/50ml 6.2. Global Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Ulcerative Colitis Rheumatoid Arthritis Ankylosing Spondylitis Crohn’s Disease Psoriatic Arthritis Plaque Psoriasis 6.3. Global Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Blood Disorders Oncology Diseases 7. Remicade Biosimilar Market Regional And Country Analysis 7.1. Global Remicade Biosimilar Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Remicade Biosimilar Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Remicade Biosimilar Market 8.1. Asia-Pacific Remicade Biosimilar Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Remicade Biosimilar Market 9.1. China Remicade Biosimilar Market Overview 9.2. China Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Remicade Biosimilar Market 10.1. India Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Remicade Biosimilar Market 11.1. Japan Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Remicade Biosimilar Market 12.1. Australia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Remicade Biosimilar Market 13.1. Indonesia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Remicade Biosimilar Market 14.1. South Korea Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Remicade Biosimilar Market 15.1. Western Europe Remicade Biosimilar Market Overview 15.2. Western Europe Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Remicade Biosimilar Market 16.1. UK Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Remicade Biosimilar Market 17.1. Germany Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Remicade Biosimilar Market 18.1. France Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Remicade Biosimilar Market 19.1. Italy Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Remicade Biosimilar Market 20.1. Spain Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Remicade Biosimilar Market 21.1. Eastern Europe Remicade Biosimilar Market Overview 21.2. Eastern Europe Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Remicade Biosimilar Market 22.1. Russia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Remicade Biosimilar Market 23.1. North America Remicade Biosimilar Market Overview 23.2. North America Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Remicade Biosimilar Market 24.1. USA Remicade Biosimilar Market Overview 24.2. USA Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Remicade Biosimilar Market 25.1. Canada Remicade Biosimilar Market Overview 25.2. Canada Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Remicade Biosimilar Market 26.1. South America Remicade Biosimilar Market Overview 26.2. South America Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Remicade Biosimilar Market 27.1. Brazil Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Remicade Biosimilar Market 28.1. Middle East Remicade Biosimilar Market Overview 28.2. Middle East Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Remicade Biosimilar Market 29.1. Africa Remicade Biosimilar Market Overview 29.2. Africa Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Remicade Biosimilar Market Competitive Landscape And Company Profiles 30.1. Remicade Biosimilar Market Competitive Landscape 30.2. Remicade Biosimilar Market Company Profiles 30.2.1. AbbVie Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Novartis AG 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Amgen Inc 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Viatris Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Teva Pharmaceutical Industries Ltd. 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Remicade Biosimilar Market Other Major And Innovative Companies 31.1. Biogen Inc. 31.2. Organon & Co. 31.3. Merck And Co. Inc. 31.4. Janssen Biotech Inc. 31.5. LG Chem Ltd. 31.6. Nippon Kayaku Co. Ltd. 31.7. Celltrion Inc. 31.8. Nichi-iko Pharmaceutical Co. Ltd. 31.9. Biocon Limited 31.10. Alvogen Inc 31.11. Synthon International Holding B.V. 31.12. Coherus Biosciences Inc 31.13. Cardinal Health Inc 31.14. Genentech Inc. 31.15. Alvotech S.A. 32. Global Remicade Biosimilar Market Competitive Benchmarking 33. Global Remicade Biosimilar Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Remicade Biosimilar Market 35. Remicade Biosimilar Market Future Outlook and Potential Analysis 35.1 Remicade Biosimilar Market In 2027 - Countries Offering Most New Opportunities 35.2 Remicade Biosimilar Market In 2027 - Segments Offering Most New Opportunities 35.3 Remicade Biosimilar Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
The Business Research Company (TBRC)社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(oncology)の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |